Impact of Vitamin D Supplementation on Cardiometabolic Risk Factors [The Daily D Health Study]
Primary Purpose
Vitamin D Deficiency
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Vitamin D3
Vitamin D3
Sponsored by
About this trial
This is an interventional prevention trial for Vitamin D Deficiency focused on measuring Vitamin D, Vitamin D Deficiency, Avitaminosis, Deficiency Diseases, Blood lipids
Eligibility Criteria
Inclusion Criteria:
- Subjects in 4th-8th grade
- Subjects must attend school where study is being conducted
- Subject and parent/guardian must give assent/consent to participate in study Related Requirements
- Subjects must complete all study visits (baseline, 3,6 and 12 months)
- Subjects must agree to be blinded
Exclusion Criteria:
- Subjects taking glucocorticoids
- Subjects not in 4th-8th grade
- Clinical diagnosis of Cystic Fibrosis
- Clinical diagnosis of Kidney disease
- Subjects currently taking a vitamin D supplement of >1000 IU/day
- Subjects diagnosed with Irritable Bowel Syndrome (IBS)
- Clinical diagnosis of AIDS
- Clinical diagnosis of Sarcoidosis
- Clinical diagnosis of Epilepsy
Sites / Locations
- Tufts University
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm Type
Active Comparator
Active Comparator
Active Comparator
Arm Label
D3 600 IU/ daily
D3 1000 IU/ daily
D3: 2000 IU/daily
Arm Description
Subjects randomized to 600 IU/day of vitamin D3 taken orally for six months.
Subjects randomized to 1000 IU/day of vitamin D3 taken orally for six months.
Subjects randomized to 2000 IU/day of vitamin D3 taken orally for six months.
Outcomes
Primary Outcome Measures
Change in vitamin D levels over six month period
Subjects will be randomized to receive one of three doses of vitamin D3. Baseline serum 25(OH)D levels will be compared to serum 25(OH)D at 3 and 6 months.
Safety Issue?: (FDAAA) No
Secondary Outcome Measures
measure serum glucose and blood lipids (total cholesterol, HDL, LDL and triglycerides) in connection with changes in vitamin D status
Baseline cardiometabolic risk factors will be compared at 3, 6 and 12 months
Full Information
NCT ID
NCT01537809
First Posted
February 17, 2012
Last Updated
December 12, 2013
Sponsor
Tufts University
Collaborators
Office of Dietary Supplements (ODS), National Heart, Lung, and Blood Institute (NHLBI), Boston University, Boston Children's Hospital
1. Study Identification
Unique Protocol Identification Number
NCT01537809
Brief Title
Impact of Vitamin D Supplementation on Cardiometabolic Risk Factors [The Daily D Health Study]
Official Title
The Impact of Vitamin D Supplementation on Cardiometabolic Risk Factors in Schoolchildren
Study Type
Interventional
2. Study Status
Record Verification Date
December 2013
Overall Recruitment Status
Completed
Study Start Date
June 2011 (undefined)
Primary Completion Date
December 2013 (Actual)
Study Completion Date
December 2013 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Tufts University
Collaborators
Office of Dietary Supplements (ODS), National Heart, Lung, and Blood Institute (NHLBI), Boston University, Boston Children's Hospital
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The purpose of this research is to determine what supplemental doses of vitamin D may be necessary to raise serum levels to optimal levels and how vitamin D supplementation and changes in vitamin D status impact cardiovascular risk factors in schoolchildren.
Detailed Description
Research suggests that vitamin D, known mainly for its role in bone health, may have other roles in the body and that vitamin D deficiency may contribute to certain chronic diseases, such as cardiovascular disease. Recently, vitamin D has received growing attention due to the increased awareness of possible deficiencies among certain populations at risk of vitamin D deficiency. Most circulating 25-hydroxyvitamin D comes from exposure to UVB rays in natural sunlight. In 2010, the Institute of Medicine issued new recommendations that daily vitamin D intakes should be increased to 600 IU/day for children ages 1-18. However, even with these recommendations in place, roughly 20% of all children are below the recommended 20 ng/mL. Moreover, more than two-thirds of all children have levels below 30 ng/mL, including 80% of Hispanic children and 92% of non-Hispanic black children. Therefore, it is imperative to gain an understanding of: 1) what supplemental doses may be necessary for schoolchildren who are already at a disadvantage in achieving optimal levels of 25(OH)D due to factors such as living at a northern latitude, having high obesity rates, and where a large proportion of the population are Latino or African American; and 2) whether serum concentrations of 25(OH)D over 30 ng/mL in children prevent health risks.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Vitamin D Deficiency
Keywords
Vitamin D, Vitamin D Deficiency, Avitaminosis, Deficiency Diseases, Blood lipids
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigator
Allocation
Randomized
Enrollment
691 (Actual)
8. Arms, Groups, and Interventions
Arm Title
D3 600 IU/ daily
Arm Type
Active Comparator
Arm Description
Subjects randomized to 600 IU/day of vitamin D3 taken orally for six months.
Arm Title
D3 1000 IU/ daily
Arm Type
Active Comparator
Arm Description
Subjects randomized to 1000 IU/day of vitamin D3 taken orally for six months.
Arm Title
D3: 2000 IU/daily
Arm Type
Active Comparator
Arm Description
Subjects randomized to 2000 IU/day of vitamin D3 taken orally for six months.
Intervention Type
Dietary Supplement
Intervention Name(s)
Vitamin D3
Intervention Description
Subjects are told to take vitamin D daily for 6 months.
Intervention Type
Dietary Supplement
Intervention Name(s)
Vitamin D3
Intervention Description
Subjects are asked to take vitamin D orally, daily for six months.
Primary Outcome Measure Information:
Title
Change in vitamin D levels over six month period
Description
Subjects will be randomized to receive one of three doses of vitamin D3. Baseline serum 25(OH)D levels will be compared to serum 25(OH)D at 3 and 6 months.
Safety Issue?: (FDAAA) No
Time Frame
Six months
Secondary Outcome Measure Information:
Title
measure serum glucose and blood lipids (total cholesterol, HDL, LDL and triglycerides) in connection with changes in vitamin D status
Description
Baseline cardiometabolic risk factors will be compared at 3, 6 and 12 months
Time Frame
12 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
9 Years
Maximum Age & Unit of Time
14 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Subjects in 4th-8th grade
Subjects must attend school where study is being conducted
Subject and parent/guardian must give assent/consent to participate in study Related Requirements
Subjects must complete all study visits (baseline, 3,6 and 12 months)
Subjects must agree to be blinded
Exclusion Criteria:
Subjects taking glucocorticoids
Subjects not in 4th-8th grade
Clinical diagnosis of Cystic Fibrosis
Clinical diagnosis of Kidney disease
Subjects currently taking a vitamin D supplement of >1000 IU/day
Subjects diagnosed with Irritable Bowel Syndrome (IBS)
Clinical diagnosis of AIDS
Clinical diagnosis of Sarcoidosis
Clinical diagnosis of Epilepsy
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jennifer Sacheck, PhD
Organizational Affiliation
Tufts University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Tufts University
City
Boston
State/Province
Massachusetts
ZIP/Postal Code
02111
Country
United States
12. IPD Sharing Statement
Citations:
PubMed Identifier
21784451
Citation
Sacheck J, Goodman E, Chui K, Chomitz V, Must A, Economos C. Vitamin D deficiency, adiposity, and cardiometabolic risk in urban schoolchildren. J Pediatr. 2011 Dec;159(6):945-50. doi: 10.1016/j.jpeds.2011.06.001. Epub 2011 Jul 23.
Results Reference
background
PubMed Identifier
34550329
Citation
Sacheck JM, Huang Q, Van Rompay MI, Chomitz VR, Economos CD, Eliasziw M, Gordon CM, Goodman E. Vitamin D supplementation and cardiometabolic risk factors among diverse schoolchildren: a randomized clinical trial. Am J Clin Nutr. 2022 Jan 11;115(1):73-82. doi: 10.1093/ajcn/nqab319.
Results Reference
derived
PubMed Identifier
29394922
Citation
Blakeley CE, Van Rompay MI, Schultz NS, Sacheck JM. Relationship between muscle strength and dyslipidemia, serum 25(OH)D, and weight status among diverse schoolchildren: a cross-sectional analysis. BMC Pediatr. 2018 Feb 2;18(1):23. doi: 10.1186/s12887-018-0998-x.
Results Reference
derived
PubMed Identifier
29029097
Citation
Sacheck JM, Van Rompay MI, Chomitz VR, Economos CD, Eliasziw M, Goodman E, Gordon CM, Holick MF. Impact of Three Doses of Vitamin D3 on Serum 25(OH)D Deficiency and Insufficiency in At-Risk Schoolchildren. J Clin Endocrinol Metab. 2017 Dec 1;102(12):4496-4505. doi: 10.1210/jc.2017-01179.
Results Reference
derived
PubMed Identifier
26936138
Citation
Sawicki CM, Van Rompay MI, Au LE, Gordon CM, Sacheck JM. Sun-Exposed Skin Color Is Associated with Changes in Serum 25-Hydroxyvitamin D in Racially/Ethnically Diverse Children. J Nutr. 2016 Apr;146(4):751-7. doi: 10.3945/jn.115.222505. Epub 2016 Mar 2.
Results Reference
derived
PubMed Identifier
26338888
Citation
Van Rompay MI, McKeown NM, Goodman E, Eliasziw M, Chomitz VR, Gordon CM, Economos CD, Sacheck JM. Sugar-Sweetened Beverage Intake Is Positively Associated with Baseline Triglyceride Concentrations, and Changes in Intake Are Inversely Associated with Changes in HDL Cholesterol over 12 Months in a Multi-Ethnic Sample of Children. J Nutr. 2015 Oct;145(10):2389-95. doi: 10.3945/jn.115.212662. Epub 2015 Sep 2.
Results Reference
derived
Learn more about this trial
Impact of Vitamin D Supplementation on Cardiometabolic Risk Factors [The Daily D Health Study]
We'll reach out to this number within 24 hrs